With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support today.
FDA Grants Emergency Use Authorization For First Coronavirus Antigen Test
The U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. in 2018. (Jacquelyn Martin/ AP)
()
The Food and Drug Administration has announced its first emergency authorization for a new type of an antigen test that can detect the coronavirus.
The test looks for protein fragments associated with the virus. The sample is collected with a nasal swab that can produce a result in minutes, the FDA said in a statement. The agency notes that compared to already approved genetic testing, the antigen test is cheaper and easier to use and could "potentially scale to test millions of Americans per day," once multiple manufacturers enter the market.
So far, only San Diego-based Quidel Corporation has received authorization for the tests. That authorization was granted late Friday.
Two other types of tests for the coronavirus have received emergency authorization. One, called a polymerase chain reaction, or PCR test, is a molecular diagnostic tool that identifies the virus' genetic material. The other is an antibody test.
Support for LAist comes from
Antigen testing is not without its shortcomings. The FDA notes the test is less reliable at ruling out infection in patients, and that negative results "may need to be confirmed with a PCR test prior to making treatment decisions or to prevent the possible spread of the virus due to a false negative."
The agency said:
"Antigen tests are very specific for the virus, but are not as sensitive as molecular PCR tests. This means that positive results from antigen tests are highly accurate, but there is a higher chance of false negatives, so negative results do not rule out infection."
READ MORE ON TESTING
- Coronavirus antibody tests explained: what are they and do they work? (The Guardian)
- What Antibody Studies Can Tell You — and More Importantly, What They Can’t (ProPublica)
Copyright 2020 NPR. To see more, visit https://www.npr.org.
At LAist, we believe in journalism without censorship and the right of a free press to speak truth to those in power. Our hard-hitting watchdog reporting on local government, climate, and the ongoing housing and homelessness crisis is trustworthy, independent and freely accessible to everyone thanks to the support of readers like you.
But the game has changed: Congress voted to eliminate funding for public media across the country. Here at LAist that means a loss of $1.7 million in our budget every year. We want to assure you that despite growing threats to free press and free speech, LAist will remain a voice you know and trust. Speaking frankly, the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news in our community.
We’re asking you to stand up for independent reporting that will not be silenced. With more individuals like you supporting this public service, we can continue to provide essential coverage for Southern Californians that you can’t find anywhere else. Become a monthly member today to help sustain this mission.
Thank you for your generous support and belief in the value of independent news.
Chip in now to fund your local journalism
(
LAist
)
Trending on LAist
-
What do stairs have to do with California’s housing crisis? More than you might think, says this Culver City councilmember. -
Yes, it's controversial, but let me explain. -
Doctors say administrator directives allow immigration agents to interfere in medical decisions and compromise medical care. -
The Palisades Fire erupted on Jan. 7 and went on to kill 12 people and destroy more than 6,800 homes and buildings. -
People moving to Los Angeles are regularly baffled by the region’s refrigerator-less apartments. They’ll soon be a thing of the past. -
Experts say students shouldn't readily forgo federal aid. But a California-only program may be a good alternative in some cases.
Best of LAist